FDA 483 - Dolan Central Illinois Compounding LLC dba Preckshot Professional Pharmacy - September 19, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Form 483 details observations from an inspection of Central Illinois Compounding, Inc. dba Preckshot Professional Pharmacy, a producer of sterile drugs located at 5832 N. Knoxville, Ave., Suite E, Peoria, IL 61614. The inspection was conducted from June 12, 2017, to September 15, 2017.
Key observations include:
1. **Drug Product Quality/Purity:** The firm released drug products (four lots of Tacrolimus 0.02% Oil Ophthalmic Solution and one lot of Cyclosporine Oil Ophthalmic Solution) where the strength, purity, or quality was deficient. This was due to the use of apparent food-grade ingredients, specifically [(b)(4)] and [(b)(4)], in their production.
2. **Sterilization Process Validation:** Procedures to prevent microbiological contamination lacked adequate validation. Observations included a pharmacy technician cleaning multiple vials with the same side of a sterile wipe, and the technician had not undergone a media fill validation since September 13, 2016, despite releasing sterile products since October 28, 2015.
3. **Aseptic Area Cleaning/Disinfection:** The system for cleaning and disinfecting aseptic processing areas and equipment was deficient. The ISO 7 gowning/anteroom failed ISO certification testing (integrity/[(b
- Inspection Date
- September 19, 2017
- Product Type
- Drugs
ID · 9b4e9bf1-1b26-4f7c-a3bb-cea1caff8fc8
Full citation text and observation details available on the Dashboard.